Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Transkriptioner
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

Cell Impact in replacement agreement, receives 6 MSEK

Cell Impact
Ladda ner börsmeddelandet

In 2024, Cell Impact entered into an agreement concerning flow plates, forming tools and fixtures with a European manufacturer, with a total contract value of SEK 18 million. Due to delays in the project, no products have been delivered to date. The parties have now agreed to replace the previous agreement with a new one, under which the customer will pay Cell Impact SEK 6 million for activities already carried out.

Under the original agreement, payment was to be made on an ongoing basis as compensation for delivered flow plates, but as project deliveries have been delayed, no such payments have been made. The new replacement agreement means that the customer, through two payments during the first half of 2026, will pay Cell Impact for work already performed, resulting in a SEK 6 million strengthening of the company's cash position for tools, fixtures and other work undertaken. After receiving SEK 1.3 million during the course of the work, this leaves undelivered products amounting to SEK 10.7 million under the original agreement, which the customer does not expect to be delivered under the current circumstances.

"The agreement is a sign of a good working relationship between us and the customer. Despite the project being affected by delays on the demand side, we are now strengthening our cash position. Moreover, there remains a joint ambition to resume product deliveries to an extent corresponding to the original agreement," says Daniel Vallin, CEO of Cell Impact.

Today's agreement will provide Cell Impact with an additional SEK 6 million in cash during the first half of 2026.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.